In a bold move to address the growing epidemic of lifestyle diseases in India, Redial Clinic has launched a nationwide ...

Glucotrack's Common Stock will continue to trade on the Nasdaq Capital Market ("Nasdaq”) under the symbol "GCTK”. The new CUSIP number for the Common Stock following the Reverse Stock Split will be ...

June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company") ...

SO-CALLED “miracle” weight-loss jabs are far less effective in the real world than in clinical trials, a major study has revealed. The new findings could have big implications for Brits ...

Braless Lottie Moss put on a very racy display in a semi-sheer black dress as she enjoyed a girls' night out at Sheesh ...

Lottie Moss has revealed she always felt 'compared' to her supermodel sister Kate as she admitted she would try weight loss jabs after suffering a seizure.

There have been rumors swirling around, though, that taking creatine causes hair loss. This mostly stems from a study published in 2009 that linked creatine to increased levels of the hormone ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

(NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345), the Company's respiratory syncytial virus (RSV) vaccine, for the prevention of lower ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.